Stocklytics Platform
Asset logo for symbol CRSP
CRISPR Therapeutics AG
CRSP57
$45.26arrow_drop_down0.83%-$0.38
Asset logo for symbol CRSP
CRSP57

$45.26

arrow_drop_down0.83%
query_stats

CRSP is not a dividend stock

Therefore Dividends subscore should not be taken into consideration

For certain stocks classified as non-dividend stocks, dividend-related data may not be available or applicable. Non-dividend stocks are those where the company does not regularly distribute dividends to its shareholders.

Why No Data?

Non-dividend stocks typically do not offer regular dividend payments. As a result, there might be no dividend-related information or history for such stocks within our database.

Understanding Non-Dividend Stocks

Non-dividend stocks are characterized by companies that reinvest their profits back into the business for expansion, research, development, or other strategic purposes rather than distributing dividends to shareholders.

What This Means for Investors

Investors in non-dividend stocks often focus on capital appreciation, anticipating the value of their shares to increase over time without relying on dividend income.

Stay Updated

While dividend information may not be available for these stocks, other critical financial metrics and analyses are accessible on Stocklytics to aid in informed investment decisions.

Stock Split History (CRSP)

DateSplitMultipleCumulative
Multiple
Jul 19, 2016333333:100000x3.3x3.3

CRISPR Therapeutics AG (CRSP) Dividends & Splits

CRISPR Therapeutics AG (CRSP) does not currently offer dividends to its shareholders. As a biotechnology company, CRISPR Therapeutics focuses on the development of gene-based therapies using its proprietary CRISPR/Cas9 gene-editing technology. The company's primary goal is to advance and commercialize potential treatments for various genetic diseases.
Similarly, CRISPR Therapeutics AG (CRSP) has not undergone any stock splits since its inception. A stock split occurs when a company divides its existing shares into multiple shares to increase liquidity and make the stock more affordable for investors. CRISPR Therapeutics AG currently trades under a single ticker symbol with no adjustments to its share structure.
add CRISPR Therapeutics AG to watchlist

Keep an eye on CRISPR Therapeutics AG

Adding the right stocks to your watchlist can provide valuable insights and opportunities for strategic decision-making.

Frequently Asked Questions

search
help

Does CRISPR Therapeutics AG (CRSP) stock pay dividends?

No, CRISPR Therapeutics AG (CRSP) does not pay dividends. This could indicate that the company is currently focusing on reinvesting its earnings into growth opportunities rather than distributing them as dividends.
help

When was the last CRISPR Therapeutics AG (CRSP) stock split?

CRISPR Therapeutics AG (CRSP) has undergone 1 total stock splits. The most recent split was a 333333:100000 split on 2016 Jul 19, leaving the company with 85.17M shares outstanding. Since the company's inception, the cumulative multiple from splits is 3.3, indicating the overall effect of all splits on the original share count.

Sign up for our newsletter

Join our exclusive community of over one million investment enthusiasts and receive our free newsletter filled with analysis, news, and updates every weekday.

Take Your Investments to a Whole New Level

Stocklytics Platform

© 2024 Stocklytics.com All rights reserved.

Stocklytics.com is not a financial advisor, and all data and information provided on this website are for informational purposes only. The content on Stocklytics.com is not intended to be a substitute for professional financial advice. Investors should conduct their own research and consult with a qualified financial advisor before making any investment decisions. Stocklytics.com makes no representations or warranties regarding the accuracy, completeness, or suitability of any information provided and is not liable for any errors or omissions, or for any losses incurred as a result of reliance on the information provided on this website.

Stocklytics Discord public channelStocklytics X Social Media